- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01541917
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis (WebSMART)
January 18, 2017 updated by: Children's Mercy Hospital Kansas City
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
The purpose of this multi-site randomized clinical trial is to determine if an online coping skills training program will produce superior improvements in pain and health-related quality of life outcomes for adolescents with JIA relative to outcomes attained with reviewing online educational information about JIA.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
There is a critical gap in the contemporary treatment of Juvenile Idiopathic Arthritis (JIA) wherein a majority of adolescent patients still experience ongoing pain and reduced health-related quality of life even with advances in medical management of the disease.
Despite the pervasiveness of this problem, most adolescents receive no training in the strategies that can help empower them to reduce pain and disability.
The Internet offers a unique opportunity to reach adolescents with JIA and provide the training in pain self-management strategies that otherwise may not occur due to treatment access and resource obstacles.
The objective of this research study is to conduct a definitive test of an investigator-developed online coping skills training program for English- and Spanish-speaking adolescents with JIA.
Based on data from the investigators' preliminary work, the central hypothesis is that use of an online coping skills training program will produce superior improvements in pain and health-related quality of life outcomes for adolescents with JIA relative to outcomes attained with reviewing extant online educational information about JIA and receiving additional attention to coping efforts (control condition).
Specific aims for the proposed work include (a) determining the extent to which an online coping skills training program for adolescents with JIA produces improvements in key health outcomes that currently do not optimally respond to only contemporary medical management (pain and health-related quality of life); and (b) determining predictors of change in pain and health-related quality of life indices in adolescents with JIA and establishing the extent to which online coping skills training influences health outcomes via these predictors.
An exploratory aim is to determine the acceptability and preliminary efficacy of online coping skills training within a subgroup of Hispanic adolescents with JIA.
These aims will be achieved through the approach of using a multi-center randomized controlled trial in which a sample of 360 consenting English- and Spanish-speaking adolescents aged 12-18 years with JIA will be enrolled and randomized into one of two groups: (a) an experimental group consisting of a 12-week interactive online multi-component treatment protocol including targeted disease education, training in empirically supported cognitive-behavioral coping skills, and social support augmented by monthly telephone contact with a nurse; or (b) a control group consisting of 12 weeks of guided access to extant online resources for disease education and additional attention to own best efforts at managing JIA via monthly telephone contact with a nurse.
Outcome data will be collected from both groups prior to treatment, immediately following the intervention, and at 6- and 12-month follow-up assessments.
Successful completion of this project is expected to establish to what extent and how an innovative online self-management program produces change in clinically relevant health outcomes in both English- and Spanish-speaking adolescents with JIA.
The proposed study therefore can be expected to have a significant positive impact in the healthcare of teens with JIA and in identifying treatment targets for other youth self-management interventions.
Study Type
Interventional
Enrollment (Actual)
305
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California San Francisco Benioff Children's Hospital
-
-
Illinois
-
Chicago, Illinois, United States, 60614-3363
- Lurie Children's Hospital
-
-
Indiana
-
Indianopolis, Indiana, United States, 46202
- Riley Hospital for Children
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Children's Mercy Hospitals and Clinics
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- Joseph M. Sanzari Children's Hospital
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University Medical Center
-
-
Ohio
-
Columbus, Ohio, United States, 43205
- Nationwide Children's Hospital
-
-
Oregon
-
Portland, Oregon, United States, 97227
- The Children's Hospital at Legacy Emmanuel Medical Center
-
-
Texas
-
Austin, Texas, United States, 78723
- Dell Children's Medical Center of Central Texas
-
-
Washington
-
Seattle, Washington, United States, 98133
- Seattle Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 12-18 years of age (inclusive)
- diagnosed with JIA by a pediatric rheumatologist
- able to speak and read English and/or Spanish
- able to complete online measures
- reporting pain in at least one joint over the past 6 months
Exclusion Criteria:
- have another chronic medical condition that adversely impacts pain and/or health-related quality of life (e.g., inflammatory bowel disease, fibromyalgia, cancer, genetic disorder, pervasive developmental disorder, diabetes)
- have a significant cognitive impairment or illiteracy that would prevent understanding of the intervention and outcome measures
- currently in psychotherapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Web-based coping skills training
Involves completion of a 12-week interactive, multi-component, multimedia online training that consists of instruction in specific self-management strategies, disease education, and social support.
|
This intervention comprises a 12-week interactive, multi-component, multimedia online training that consists of instruction in specific self-management strategies, disease education, and social support.
The content is rooted in cognitive-behavioral principles of disease self-management.
In addition to the web-based modules, the intervention consists of monthly telephone support for 3 months by a trained bilingual health coach (research nurse) to review material and help enhance motivation.
|
|
Active Comparator: Online disease education
Involves viewing 12 educational websites about Juvenile Idiopathic Arthritis over the course of 12 weeks.
|
The online disease education intervention provides access to an online resource center containing links to 12 educational websites about Juvenile Idiopathic Arthritis.
Participants will be asked to review one educational website per week over the course of 12 weeks.
Participants also will receive three monthly phone calls by a bilingual nurse "health coach" to discuss the participant's efforts at managing his/her disease.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pain Intensity
Time Frame: Baseline, post-treatment, 6-month follow-up, 12-month follow-up
|
Pain intensity was assessed by patient-self report using an electronic numeric rating scale ranging from 0-10, with 0 being the lowest value ("no pain") and 10 being the highest value ("very much pain").
|
Baseline, post-treatment, 6-month follow-up, 12-month follow-up
|
|
Change in PedsQL Rheumatology Health-Related Quality of Life Total Score
Time Frame: Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
|
Health-related quality of life was measured by patient self-report using an electronic version of the PedsQL Rheumatology Module.
Responses on this scale are transformed into a 0-100 scale, with 0 being the worst value for health-related quality of life and 100 being the best possible value for health-related quality of life.
|
Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Medical Issues, Exercise, Pain and Social Support Questionnaire (MEPS) Education Score
Time Frame: Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
|
Knowledge about Juvenile Idiopathic Arthritis was measured by patient self-report using an electronic version of the Medical Issues, Exercise, Pain and Social support (MEPS) Questionnaire.
Responses on this scale are measured on a 0-10 numeric rating scale and averaged together to form a summary score, with 0 being the worst possible score and 10 being the best possible score.
|
Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
|
|
Change in Disease Activity
Time Frame: Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
|
Disease activity was assessed by the treating physician based on a complete joint count (count of the number of joints that are swollen, painful, tender, or restriction in motion).
The lowest (best) value is 0, and the highest (worst) possible value is 300.
|
Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
|
|
Change in Children's Arthritis Self-Efficacy (CASE) Scores
Time Frame: Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
|
Confidence in managing arthritis was measured by patient self-report using an electronic version of the Children's Arthritis Self-Efficacy (CASE) scale.
Responses on a 5-point scale ("not at all sure" to "very sure") are averaged together to form a total score, with 0 being the worst possible value and 5 being the best possible value.
|
Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
|
|
Change in Approach Coping
Time Frame: Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
|
Scores on the Approach Coping sub-scale of the Pain Coping Questionnaire were used to measure approach coping, which is a type of coping considered to be adaptive and helpful for pain.
Responses to items on this subscale are on a 5-point scale ("never use" to "very often use") and are averaged together for the subscale score, such that scores range from a worst possible value of 1 to a best possible value of 5.
|
Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mark A Connelly, PhD, Children's Mercy Hospital Kansas City
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Actual)
April 1, 2016
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
February 24, 2012
First Submitted That Met QC Criteria
February 24, 2012
First Posted (Estimate)
March 1, 2012
Study Record Updates
Last Update Posted (Actual)
March 9, 2017
Last Update Submitted That Met QC Criteria
January 18, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GRANT10829275
- 1R01AR061513-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
A deidentified dataset is available for secondary analyses per our Resource Sharing Plan.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Juvenile Idiopathic Arthritis
-
University of AarhusAarhus University HospitalCompletedPolyarticular Juvenile Rheumatoid Arthritis | Systemic Juvenile Idiopathic Arthritis | Juvenile Idiopathic Arthritis, OligoarthritisDenmark
-
Bangladesh Medical UniversityCompletedJuvenile Idiopathic Arthritis | Polyarticular Juvenile Idiopathic Arthritis | Refractory Polyarticular Juvenile Idiopathic ArthritisBangladesh
-
Assiut UniversityNot yet recruitingJuvenile Idiopathic Arthritis | Tenosynovitis | Polyarticular Juvenile Idiopathic Arthritis | Oligoarticular Juvenile Idiopathic Arthritis
-
Changchun GeneScience Pharmaceutical Co., Ltd.RecruitingActive Systemic Juvenile Idiopathic ArthritisChina
-
Novartis PharmaceuticalsPediatric Rheumatology International Trials OrganizationCompletedSystemic Juvenile Idiopathic Arthritis With Active FlareUnited States, Argentina, Canada, Switzerland, Germany, Israel, South Africa, Belgium, Italy, Spain, France, Brazil, Turkey, Hungary, Poland, Norway, Sweden, Netherlands, Peru
-
Novartis PharmaceuticalsCompletedSystemic Juvenile Idiopathic Arthritis (SJIA)Italy, Russian Federation, Turkey, Belgium, Spain, Germany, France, Israel, Canada, United States, Hungary, Austria, Brazil, Sweden, Netherlands, Poland
-
PfizerRecruitingPolyarticular Juvenile Idiopathic Arthritis | Psoriatic Arthritis, JuvenileSouth Korea
-
NovartisCompletedArthritis, Juvenile RheumatoidItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaNot yet recruitingSystemic Juvenile Idiopathic Arthritis (sJIA)Italy
-
University of British ColumbiaUniversity of Manitoba; The Hospital for Sick Children; McGill University Health... and other collaboratorsRecruiting
Clinical Trials on Web-based coping skills training
-
State University of New York at BuffaloUniversity of OregonActive, not recruitingAlcohol AbuseUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedDepression | Lung Diseases
-
Duke UniversityAmerican Cancer Society, Inc.Completed
-
Ohio UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedCardiorespiratory FailureUnited States
-
Duke UniversityCompletedPCST-Full (Pain Coping Skills Training) | PCST-BriefUnited States
-
Hacettepe UniversityEnrolling by invitation
-
Duke UniversityCompletedHematopoietic Neoplasms (Leukemia, Lymphoma, Multiple Myeloma)United States
-
Children's Hospital and Health System Foundation...University of Wisconsin, MadisonCompletedEpilepsy | Asthma | Spina Bifida | Rheumatologic Conditions (JRA,Lupus)United States
-
Istituto Auxologico ItalianoCompletedPsychological StressItaly